NEWS

See our latest news and events

Comming soon

Our next news and events are coming soon

Comming soon

Our next news and events are coming soon

Latest news

See our traces

NetTargets presented at BIO KOREA 2023.

Je-Hoon Song, CITO of NetTargets, delivered a presentation titled "Discovery of Mechanism-based Drug Targets through the Integration of Artificial Intelligence and Systems Biology" at the BIO KOREA 2023 on May 11th, 2023.

NetTargets has been selected as the Most Innovative Drug Discovery Company in East Asia at the Global Health and Pharma Biotechnology Awards 2023.

We are delighted to announce that NetTargets has been named the Most Innovative Drug Discovery Company in East Asia at the Global Health and Pharma Biotechnology Awards 2023.

NetTargets will deliver a presentation at BIO KOREA 2023.

NetTargets will deliver a presentation at BIO KOREA 2023, to be held on 10-12 May at COEX, SEOUL (Presentation Schedule: May 11, 2023, 10:40 AM (KST)). It will also participate in partnering meetings and exhibit at the booth (no. Q25) during the conference.

NetTargets and Samsung Medical Center signed MoU on new drug research collaboration

NetTargets has partnered with Samsung Medical Center for a new drug research collaboration using NetTargets’ N-MAP and N-CAP, which are "AI-enhanced systems biology" -based drug development platforms.

NetTargets will virtually present at Biotech showcase 2023.

NetTargets will deliver a virtual presentation at Biotech Showcase™ 2023, to be held on 09-11 January (Presentation Schedule : January 09 2023, 2:00 PM(PST)). It will also participate in the virtual partnering meeting on 18-19 January 2023.
*The presentation video is included.

NetTargets and Daewoong Therapeutics signed MoU on anticancer drug research collaboration

NetTargets has partnered with Daewoong Therapeutics, for an anticancer drug research collaboration using NetTargets N-Map and N-Cap which are "AI-enhanced systems biology" based drug development platforms.

NetTargets Inc. is introduced as one of the rising AI startup

The Korea Economic Daily introduced NetTargets Inc. as a rising AI startup, featuring its technology as the golden-egg goose.

NetTargets Inc. is selected for the Korea AI Startup 100

Korea AI Startup 100 is a project to discover next-generation unicorn companies in the field of artificial intelligence (AI).

NetTargets and Cellkey sign MoU to collaborate on biomarker discovery

NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.

NetTargets will present at KASBP's eSymposium on June 4.

Jaehong Shin, CDO of NetTargets will present at Korean American Society in Biotech and Pharmaceuticals (KASBP) eSymposium on June 4, 2021 about computational approaches for early phase drug discovery research in the age of AI.

NetTargets Inc. is selected as one of 25 notable AI startups in 2021 by AI Times.

AI Times recognized NetTargets as one of the notable AI startups in biopharmaceuticals in 2021.

NetTargets Inc. is selected as one of TOP 10 BIOTECH STARTUPS IN APAC 2020 by Startupcity magazine.

We are pleased to be one of top 10 biotech startsups in APAC 2020 selected by Startupcity magazine.

NetTargets Inc. participates at Bluepoint demo day 2020 on Nov 24.

In this 7th Bluepoint demo day, NetTargets explained how we are solving problems from traditional industries with our technologies.

Biospectator Interview

NetTargets introduced the core platforms N-MAP and N-CAP at the Biopharma Tech concert on May 21st.

[Biotech Showcase 2020] Proactive Director Interviews - NetTargets

NetTargets, Inc CFO Jongho Baek sat down with Proactive at the Biotech Showcase 2020 in San Francisco.

NetTargets Inc. will present at Biotech showcase 2020 in San francisco

NetTargets announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square.

NetTargets selected for the TIPS Program with AI-enhanced Systems Biology for Drug Development

NetTargets was selected for the TIPS program with accelerator Bluepoint Partners, so it will receive over $600K in R&D expenses.

NetTargets invited to present as a promising startup at LG Bio-science forum

NetTargets, a KAIST spin-out company, presented its world-leading Systems Biology technologies for drug development at LG Bio-science Forum.

Establishment announcement

We are proud to announce that NetTargets Inc. has been officially established as of 13 August 2019

Comming soon

Our next news and events are coming soon

Comming soon

Our next news and events are coming soon

Comming soon

Our next news and events are coming soon

SITEMAP

CONTACT US